How to buy ENDRA Life Sciences stock | $2.12

ENDRA Life Sciences Inc is a diagnostics & research business based in the US. ENDRA Life Sciences shares (NDRA) are listed on the NASDAQ and all prices are listed in US Dollars. ENDRA Life Sciences employs 18 staff and has a market cap (total outstanding shares value) of 0.00.

ENDRA Life Sciences stock price (NASDAQ: NDRA)

Use our graph to track the performance of NDRA stocks over time.

ENDRA Life Sciences shares at a glance

• Key figures

Information last updated 2021-07-28.

Latest market close	$2.12
52-week range	$0.67 - $3.10
50-day moving average	$2.07
200-day moving average	$2.21
Wall St. target price	$6.00
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-1.63

Buy ENDRA Life Sciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy ENDRA Life Sciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of ENDRA Life Sciences Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

ENDRA Life Sciences price performance over time

Historical closes compared with the close of $2.12 from 2021-05-28

1 week (2021-07-22)	N/A
1 month (2021-07-02)	0.95%
3 months (2021-04-30)	-11.67%
6 months (2021-01-29)	N/A

1 year (2020-07-29)	N/A
2 years (2019-07-29)	N/A
3 years (2018-07-29)	N/A
5 years (2016-07-29)	N/A

ENDRA Life Sciences financials

Gross profit TTM	$0
Return on assets TTM	-58.9%
Return on equity TTM	-104.76%
Profit margin	0%
Book value	$0.43
Market capitalisation	$75.4 million

TTM: trailing 12 months

Shorting ENDRA Life Sciences shares

There are currently 827,076 ENDRA Life Sciences shares held short by investors – that's known as ENDRA Life Sciences's "short interest". This figure is 7.9% up from 766,780 last month.

There are a few different ways that this level of interest in shorting ENDRA Life Sciences shares can be evaluated.

ENDRA Life Sciences's "short interest ratio" (SIR)

ENDRA Life Sciences's "short interest ratio" (SIR) is the quantity of ENDRA Life Sciences shares currently shorted divided by the average quantity of ENDRA Life Sciences shares traded daily (recently around 437606.34920635). ENDRA Life Sciences's SIR currently stands at 1.89. In other words for every 100,000 ENDRA Life Sciences shares traded daily on the market, roughly 1890 shares are currently held short.

However ENDRA Life Sciences's short interest can also be evaluated against the total number of ENDRA Life Sciences shares, or, against the total number of tradable ENDRA Life Sciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ENDRA Life Sciences's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 ENDRA Life Sciences shares in existence, roughly 20 shares are currently held short) or 0.0216% of the tradable shares (for every 100,000 tradable ENDRA Life Sciences shares, roughly 22 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against ENDRA Life Sciences.

Find out more about how you can short ENDRA Life Sciences stock.

ENDRA Life Sciences share dividends

We're not expecting ENDRA Life Sciences to pay a dividend over the next 12 months.

ENDRA Life Sciences share price volatility

Over the last 12 months, ENDRA Life Sciences's shares have ranged in value from as little as $0.667 up to $3.1. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ENDRA Life Sciences's is 1.2332. This would suggest that ENDRA Life Sciences's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

ENDRA Life Sciences overview

ENDRA Life Sciences Inc. develops technology for clinical diagnostic ultrasound. It develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood for the treatment of nonalcoholic fatty liver disease, as well as temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. The company also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

Frequently asked questions

What percentage of ENDRA Life Sciences is owned by insiders or institutions?
Currently 2.58% of ENDRA Life Sciences shares are held by insiders and 9.14% by institutions. How many people work for ENDRA Life Sciences?
Latest data suggests 18 work at ENDRA Life Sciences. When does the fiscal year end for ENDRA Life Sciences?
ENDRA Life Sciences's fiscal year ends in December. Where is ENDRA Life Sciences based?
ENDRA Life Sciences's address is: 3600 Green Court, Ann Arbor, MI, United States, 48105-1570 What is ENDRA Life Sciences's ISIN number?
ENDRA Life Sciences's international securities identification number is: US29273B1044 What is ENDRA Life Sciences's CUSIP number?
ENDRA Life Sciences's Committee on Uniform Securities Identification Procedures number is: 29273B104